ECSP003603A - COMMON SALT AND MOXIFLOXACIN FORMULATION - Google Patents
COMMON SALT AND MOXIFLOXACIN FORMULATIONInfo
- Publication number
- ECSP003603A ECSP003603A ECSP003603A ECSP003603A EC SP003603 A ECSP003603 A EC SP003603A EC SP003603 A ECSP003603 A EC SP003603A EC SP003603 A ECSP003603 A EC SP003603A
- Authority
- EC
- Ecuador
- Prior art keywords
- formulation
- common salt
- moxifloxacin formulation
- moxifloxacin
- medicament
- Prior art date
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000011780 sodium chloride Substances 0.000 title abstract 2
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 title 1
- 229960003702 moxifloxacin Drugs 0.000 title 1
- 235000002639 sodium chloride Nutrition 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000013011 aqueous formulation Substances 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960005112 moxifloxacin hydrochloride Drugs 0.000 abstract 1
- IDIIJJHBXUESQI-DFIJPDEKSA-N moxifloxacin hydrochloride Chemical compound Cl.COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 IDIIJJHBXUESQI-DFIJPDEKSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presenrte invención se refiere a una formulación acuosa que contiene clorhidrato de moxifloxacina y cloruro sódico, a la formulación para su uso como medicamenrto y al uso de la formación para la fabricación de un medicamento para la prevención o tratamiento de infecciones bacterianas en hombres o animales.The present invention relates to an aqueous formulation containing moxifloxacin hydrochloride and sodium chloride, to the formulation for use as a medicament and to the use of the formulation for the manufacture of a medicament for the prevention or treatment of bacterial infections in humans or animals. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003603 ECSP003603A (en) | 2000-08-03 | 2000-08-03 | COMMON SALT AND MOXIFLOXACIN FORMULATION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003603 ECSP003603A (en) | 2000-08-03 | 2000-08-03 | COMMON SALT AND MOXIFLOXACIN FORMULATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003603A true ECSP003603A (en) | 2000-09-22 |
Family
ID=42041210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003603 ECSP003603A (en) | 2000-08-03 | 2000-08-03 | COMMON SALT AND MOXIFLOXACIN FORMULATION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003603A (en) |
-
2000
- 2000-08-03 EC ECSP003603 patent/ECSP003603A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26269A1 (en) | COMMON SALT AND MOXIFLOXACIN FORMULATION | |
| HN1999000183A (en) | PHARMACEUTICAL PREPARATION FOR MOXIFLOXACIN | |
| NO20042271L (en) | Formulations containing a cephalosporin compound and their use in the treatment of bacterial infections in cats and dogs | |
| ES2146300T3 (en) | USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS. | |
| AR013488A1 (en) | AQUEOUS GERMICIDAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF INFECTIOUS DISEASES OF ANIMAL FISH, AND USE OF SUCH COMPOSITION | |
| BRPI0416796A (en) | organic compounds | |
| ATE531419T1 (en) | DEVICE FOR ADMINISTRATION OF THERAPEUTIC AGENTS | |
| CO5180582A1 (en) | PHARMACEUTICAL SOLUTIONS OF LEVOSIMENDAN | |
| TR200200716T2 (en) | Quetiapine granules | |
| PT1272199E (en) | COMBINATION THERAPIES WITH LESAO VASCULAR ACTIVITY | |
| TR200101649T2 (en) | Piperazine derivatives. | |
| ECSP044985A (en) | SINGLE DOSE AZITHROMYCIN FOR RESPIRATORY INFECTIONS | |
| ATE357212T1 (en) | AQUEOUS PHARMACEUTICAL SOLUTION CONTAINING OXYMETAZOLINE AND/OR XYLOMETAZOLINE | |
| AR052855A1 (en) | COMPOSITIONS FOR ORAL CARE CONTAINING AN EUCALYPTUS EXTRACT | |
| UY28542A1 (en) | ANTIBACTERIAL MACROCYCLIC AMIDES | |
| AR043117A1 (en) | TREATMENT OF BACTERIAL DISEASES OF RESPIRATORY ORGANS | |
| AR030378A1 (en) | EMPLOYMENT OF TRIAZINTRION-SULPHONES FOR THE FIGHT AGAINST COCCIDIOSIS | |
| CL2008001279A1 (en) | Method for enhancing the antimicrobial activity of a formulation comprising an n-halogenated amino acid comprising a phase transfer agent; formulation; method of disinfecting surfaces and contact lenses; method of treating a tissue infection and of treating respiratory infections. | |
| BR0318659A (en) | proline derivatives used as active pharmaceutical ingredients in the treatment of tumors | |
| AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| DE60318395D1 (en) | R - (-) - 1-i2- (7-CHLOROBENZO-iB -THIOPHEN-3-YL-METHOXY) -2- (2,4-DICHLORPHENYL) ETHYL-1H-IMIDAZOLE | |
| ECSP003603A (en) | COMMON SALT AND MOXIFLOXACIN FORMULATION | |
| BRPI0411524A (en) | pharmaceutical formulation of amoxicillin and clavulanate, use of sodium carboxymethylcellulose, and method of treating bacterial infection in pediatric patients | |
| BR0317292A (en) | Anthranic acid amide derivatives and their pharmaceutical use | |
| HUP0202888A2 (en) | Medicaments that contain xenogenic oligo- or/and polyribonucleotides |